Your session is about to expire
← Back to Search
Treatment for Pancreatic Cancer
N/A
Recruiting
Research Sponsored by Hoag Memorial Hospital Presbyterian
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights
No Placebo-Only Group
Summary
This is an observational, biospecimen collection protocol to develop a bank of pancreatic cancer tissue and normal tissue.
Eligible Conditions
- Pancreatic Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Measuring cell-free and exosomal-miRNA biomarkers using small RNA-Seq in matched tissue and plasma from patients with PDAC, PNs, pancreatitis and normal pancreas for early detection.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Find a Location
Who is running the clinical trial?
Hoag Memorial Hospital PresbyterianLead Sponsor
35 Previous Clinical Trials
17,121 Total Patients Enrolled
Baylor Research InstituteOTHER
206 Previous Clinical Trials
203,325 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger